These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3609332)

  • 1. Medical management of hyperprolactinemia: a lower dose of bromocriptine may be effective.
    Soto-Albors CE; Randolph JF; Ying YK; Riddick DH
    Fertil Steril; 1987 Aug; 48(2):213-7. PubMed ID: 3609332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
    Kletzky OA; Vermesh M
    Fertil Steril; 1989 Feb; 51(2):269-72. PubMed ID: 2912773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
    Moro M; Maraschini C; Toja P; Masala A; Alagna S; Rovasio PP; Ginanni A; Lancranjan I; Cavagnini F
    Horm Res; 1991; 35(3-4):137-41. PubMed ID: 1806467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
    Gianola D; Pedroncelli A; Montini M; Tengattini F; Pagani MD; Cortesi L; Cappi MP; Gherardi F; Lancranjan I; Pagani G
    Gynecol Endocrinol; 1991 Sep; 5(3):213-6. PubMed ID: 1776507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin (PRL) response to oral or vaginal bromoergocriptine in hyperprolactinemic women.
    Dash RJ; Ajmani AK; Sialy R
    Horm Metab Res; 1994 Mar; 26(3):164. PubMed ID: 8005568
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A; Landi ML; Cappabianca P; Di Salle F; Rossi FW; Pivonello R; Di Somma C; Faggiano A; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
    Moriondo P; Travaglini P; Nissim M; Conti A; Faglia G
    J Clin Endocrinol Metab; 1985 Apr; 60(4):764-72. PubMed ID: 3919052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term treatment with oral single administration of bromocriptine in patients with hyperprolactinemia.
    Ciccarelli E; Mazza E; Ghigo E; Guidoni F; Barberis A; Massara F; Camanni F
    J Endocrinol Invest; 1987 Feb; 10(1):51-3. PubMed ID: 3598074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
    Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
    J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
    Parra A; Crespo G; Coria I; Espinosa de los Monteros A
    Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience.
    Arduc A; Gokay F; Isik S; Ozuguz U; Akbaba G; Tutuncu Y; Berker D; Kucukler FK; Aydin Y; Guler S
    J Endocrinol Invest; 2015 Apr; 38(4):447-53. PubMed ID: 25421155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.
    Verhelst JA; Froud AL; Touzel R; Wass JA; Besser GM; Grossman AB
    Acta Endocrinol (Copenh); 1991 Oct; 125(4):385-91. PubMed ID: 1683503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women.
    Vermesh M; Fossum GT; Kletzky OA
    Obstet Gynecol; 1988 Nov; 72(5):693-8. PubMed ID: 3173919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia.
    Darwish AM; El-Sayed AM; El-Harras SA; Khaled KA; Ismail MA
    Fertil Steril; 2008 Nov; 90(5):1864-8. PubMed ID: 18462734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal bromocriptine--clinical and biochemical effects.
    Ginsburg J; Hardiman P; Thomas M
    Gynecol Endocrinol; 1992 Jun; 6(2):119-26. PubMed ID: 1502929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia.
    Lamberts SW; Quik RF
    J Clin Endocrinol Metab; 1991 Mar; 72(3):635-41. PubMed ID: 1997518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
    Fukunaga T
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.